1999
DOI: 10.1016/s0300-483x(99)00122-5
|View full text |Cite
|
Sign up to set email alerts
|

Carcinogenicity testing in the CD-1 mouse of a prospective insect repellant (KBR 3023) using the dermal route of exposure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2000
2000
2017
2017

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…In 1999, the Bayer group substituted the active agent in their products. For example, in the insect repellent Autan®, DEET was replaced by Bayrepel (1-piperidine carboxylic acid-2-(2-hydroxyethyl)-1-methylpropyl ester), which is as efficient as DEET and has no known adverse effects (Wahle et al 1999). However, there are still products on the market containing DEET as the active agent.…”
mentioning
confidence: 99%
“…In 1999, the Bayer group substituted the active agent in their products. For example, in the insect repellent Autan®, DEET was replaced by Bayrepel (1-piperidine carboxylic acid-2-(2-hydroxyethyl)-1-methylpropyl ester), which is as efficient as DEET and has no known adverse effects (Wahle et al 1999). However, there are still products on the market containing DEET as the active agent.…”
mentioning
confidence: 99%
“…In an oncogenicity study (Wahle et al, 1999a), Picaridin was administered dermally on the dorsal aspect of the trunk to 50 CD-1 mice/sex/dose at dose levels of 0, 50, 100, or 200 mg/kg/day on 5 consecutive days/week for 18 months. No toxicity or evidence of an oncogenic potential was observed at any dose level, up to and including the HDT of 200 mg/kg/day.…”
Section: Oncogenicity In the Mousementioning
confidence: 99%